Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.36 USD
Change Today -0.01 / -0.73%
Volume 843.7K
AVEO On Other Exchanges
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tuan Ha-Ngoc

AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Tuan Ha-Ngoc served as an Executive Advisor of Aveo Pharmaceuticals, Inc. from January 6, 2015 to January 31, 2015. Mr. Ha-Ngoc served as President and Chief Executive Officer of Aveo Pharmaceuticals, Inc. (formerly, GenPath Pharmaceuticals, Inc.) from June 2002 to January 7, 2015. Mr. Ha-Ngoc served as Acting Chief Financial Officer of Aveo Pharmaceuticals, Inc. since December 30, 2013 and its Principal Accounting Officer until July 2014. He Co-founded deNovis Inc. ...

Read Full Background

Corporate Headquarters*

650 East Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-299-5000
Fax: --

Board Members Memberships*



Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

Total Annual Compensation$567,875

Stock Options*

All Other Compensation$12,044
Exercisable Options985,433
Unexercisable Options1,045,063
Total Number of Options2,030,496

Total Compensation*

Total Annual Cash Compensation$579,919
Total Short Term Compensation$567,875
Other Long Term Compensation$12,044
Total Calculated Compensation$1,386,516
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVEO:US $1.36 USD -0.01


Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
Andrew Philip Witty Chief Executive Officer, Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline S.A.E
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at